It’s called SenSight * and it’s an anti-Parkinson’s ‘pacemaker’, a directional lead system developed by Medtronic for Deep Brain Stimulation (Dbs) therapy. “A directional stimulation that allows you to customize the therapy, and to provide individual and patient-specific data thanks to the sensing function for detecting brain signals”: these, explains the company, are the innovative features of the new device, used together with the neurostimulator. Percept * PC introduced to the market last year.
Read Also
- Cars | Incorrect guidance on car scrapping premiums has so far resulted in an additional bill of EUR 1.5 million for the state Jul 13, 2021
- WWDC 2022: minute by minute of Apple’s special event Jun 6, 2022
- mun. de Tirúa dismisses the head of the Secplan after complaints by officials for sexual harassment and abuse Nov 24, 2022
- Guadeloupe: The region files a complaint for a “large-scale cyberattack” Nov 22, 2022
- “Do not touch my post”: A program that mainly affects older viewers Nov 25, 2022
- Seine-Saint-Denis: A pavilion converted into a brothel, two suspects imprisoned Nov 20, 2022
- Notre-Dame-des-Landes: Ten years later, they celebrate the failure of the first dismantling of the ZAD Nov 20, 2022